Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

MAb from Hayashibara with IFN-inducing properties

Jan. 23, 1997

Drug screening technology available for licensing

Jan. 22, 1997

n-Docosanol efficacy demonstrated in herpes labialis

Jan. 21, 1997

Shaman patents new antifungal agents

Jan. 21, 1997

Abbott isolates fusacandin antifungal agents

Jan. 20, 1997

Tularik, Merck & Co. extend R&D agreement

Jan. 17, 1997

Takeda discloses lankacidin derivatives

Jan. 17, 1997

Generic version of Monistat-7 approved by FDA

Jan. 16, 1997

New approvals for Zagam

Jan. 16, 1997

Biochemie reports new cephalosporins

Jan. 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...